Zoe Moodie
19PUBLICATIONS
140CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (19)
Sort by Publication Date:
|Apr 02, 2026
Comparing HIV Vaccine Immunogenicity Across Trials With Different Populations and Study Designs.Yutong Jin, Alex Luedtke, Zoe Moodie
|Jul 30, 2025
Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial.K Rachael Parks, Zoe Moodie, Mary A Allen
|Apr 28, 2025
High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302).Sharon A Riddler, Zoe Moodie, Jesse Clark
|Apr 11, 2025
ALVAC-prime and monomeric gp120 protein boost induces distinct HIV-1 specific humoral and cellular responses compared with adenovirus-prime and trimeric gp140 protein boost.Leigh H Fisher, Erica Lazarus, Chenchen Yu
|Sep 20, 2024
Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1-2 randomized double-blind placebo-controlled trial.Vimla Naicker, Fatima Laher, Linda-Gail Bekker
|Jun 26, 2024
A gH/gL-encoding replicon vaccine elicits neutralizing antibodies that protect humanized mice against EBV challenge.Kristina R Edwards, Harman Malhi, Karina Schmidt
Pageof 4
Frequent Collaborators
6 joint publications
Kristen W Cohen
6 joint publications
M Juliana McElrath
6 joint publications
Fatima Laher
4 joint publications
Mary Allen
4 joint publications
Stephen R Walsh
4 joint publications
Maurine D Miner
4 joint publications
David Montefiori
4 joint publications
Kelly E Seaton
4 joint publications
Lawrence Corey
4 joint publications
Nicole Grunenberg
